Showing results (781-790 of 2,706) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|February 1, 2005
Infection in breast implantsBrigitte Pittet, Denys Montandon, Didier Pittet
The Lancet. Infectious Diseases|December 23, 2021
Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend studyYang Zheng, Qi Yu, Yushi Lin, et al.
The Lancet. Infectious Diseases|December 2, 2021
Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trialEveline Hürlimann, Ladina Keller, Chandni Patel, et al.
The Lancet. Infectious Diseases|September 5, 2022
Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational studyMegan Bardsley, Roger A Morbey, Helen E Hughes, et al.
The Lancet. Infectious Diseases|September 10, 2022
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trialMehreen S Datoo, Hamtandi Magloire Natama, Athanase Somé, et al.
The Lancet. Infectious Diseases|September 10, 2022
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studiesHelen S Marshall, Timo Vesikari, Peter C Richmond, et al.
The Lancet. Infectious Diseases|January 20, 2022
Fluid therapy for severe malariaLaura C Kalkman, Thomas Hänscheid, Sanjeev Krishna, et al.
The Lancet. Infectious Diseases|November 26, 2021
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trialPeter G Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana-Arri, et al.
The Lancet. Infectious Diseases|November 21, 2021
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trialMahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
The Lancet. Infectious Diseases|October 23, 2022
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trialDaniela Manno, Agnes Bangura, Frank Baiden, et al.
Pageof 271